MeSH Review:
Hyperparathyroidism, Secondary
Sanchez,
He,
Slatopolsky,
Finch,
Ritter,
Takahashi,
Serhan,
Newton,
Ali,
Walford,
Singh,
Shiizaki,
Negi,
Hatamura,
Sakaguchi,
Saji,
Kunimoto,
Mizobuchi,
Imazeki,
Ooshima,
Akizawa,
Erben,
Soegiarto,
Weber,
Zeitz,
Lieberherr,
Gniadecki,
Möller,
Adamski,
Balling,
Echenique Elizondo,
Díaz-Aguirregoitia,
Amondarain,
Vidaur,
- Calreticulin inhibits vitamin D's action on the PTH gene in vitro and may prevent vitamin D's effect in vivo in hypocalcemic rats. Sela-Brown, A., Russell, J., Koszewski, N.J., Michalak, M., Naveh-Many, T., Silver, J. Mol. Endocrinol. (1998)
- Activation of the calcium receptor by a calcimimetic compound halts the progression of secondary hyperparathyroidism in uremic rats. Chin, J., Miller, S.C., Wada, M., Nagano, N., Nemeth, E.F., Fox, J. J. Am. Soc. Nephrol. (2000)
- Daily or intermittent calcitriol administration during growth hormone therapy in rats with renal failure and advanced secondary hyperparathyroidism. Sanchez, C.P., He, Y.Z. J. Am. Soc. Nephrol. (2005)
- Sevelamer hydrochloride attenuates kidney and cardiovascular calcifications in long-term experimental uremia. Cozzolino, M., Staniforth, M.E., Liapis, H., Finch, J., Burke, S.K., Dusso, A.S., Slatopolsky, E. Kidney Int. (2003)
- Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate, and vitamin D. Naveh-Many, T., Rahamimov, R., Livni, N., Silver, J. J. Clin. Invest. (1995)
- Reversal of secondary hyperparathyroidism by cimetidine in chronically uremic dogs. Jacob, A.I., Canterbury, J.M., Gavellas, G., Lambert, P.W., Bourgoignie, J.J. J. Clin. Invest. (1981)
- The relative roles of calcium, phosphorus, and parathyroid hormone in glucose- and tolbutamide-mediated insulin release. Harter, H.R., Santiago, J.V., Rutherford, W.E., Slatopolsky, E., Klahr, S. J. Clin. Invest. (1976)
- Phosphate and the development of nephrocalcinosis in rats fed diets containing alpha protein. Zalups, R.K., Haase, P., Philbrick, D.J. Am. J. Pathol. (1983)
- Biochemical and cellular effects of direct maxacalcitol injection into parathyroid gland in uremic rats. Shiizaki, K., Negi, S., Hatamura, I., Sakaguchi, T., Saji, F., Kunimoto, K., Mizobuchi, M., Imazeki, I., Ooshima, A., Akizawa, T. J. Am. Soc. Nephrol. (2005)
- Differential effects of 1,25-dihydroxy-vitamin D3 and 19-nor-1,25-dihydroxy-vitamin D2 on calcium and phosphorus resorption in bone. Finch, J.L., Brown, A.J., Slatopolsky, E. J. Am. Soc. Nephrol. (1999)
- Prevalence of hypovitaminosis D in Indo-Asian patients attending a rheumatology clinic. Serhan, E., Newton, P., Ali, H.A., Walford, S., Singh, B.M. Bone (1999)
- Calcium paradox of aldosteronism and the role of the parathyroid glands. Vidal, A., Sun, Y., Bhattacharya, S.K., Ahokas, R.A., Gerling, I.C., Weber, K.T. Am. J. Physiol. Heart Circ. Physiol. (2006)
- Activation of renal adenylate cyclase by forskolin: assessment of enzymatic activity in animal models of the secondary hyperparathyroid state. Forte, L.R. Arch. Biochem. Biophys. (1983)
- The effect of high-dose salmon calcitonin on bone mineral metabolism in the normal rat. Glajchen, N., Thomas, S., Jowell, P., Epstein, S., Ismail, F., Fallon, M. Calcif. Tissue Int. (1990)
- Vitamin E deficiency reduced lumbar bone calcium content in female rats. Norazlina, M., Chua, C.W., Ima-Nirwana, S. Med. J. Malaysia (2004)
- Effect of chronic renal failure on Ca2+ ATPase of brain synaptosomes. Hajjar, S.M., Smogorzewski, M., Zayed, M.A., Fadda, G.Z., Massry, S.G. J. Am. Soc. Nephrol. (1991)
- Gp130-mediated signaling is necessary for normal osteoblastic function in vivo and in vitro. Shin, H.I., Divieti, P., Sims, N.A., Kobayashi, T., Miao, D., Karaplis, A.C., Baron, R., Bringhurst, R., Kronenberg, H.M. Endocrinology (2004)
- PTH/PTHrP receptor mRNA is down-regulated in epiphyseal cartilage growth plate of uraemic rats. Ureña, P., Ferreira, A., Morieux, C., Drüeke, T., de Vernejoul, M.C. Nephrol. Dial. Transplant. (1996)
- Impaired activity of alpha-ketoglutarate dehydrogenase of heart mitochondria in chronic renal failure: role of secondary hyperparathyroidism. Perna, A.F., Zayed, M.A., Massry, S.G. Nephron (1991)
- Fluoride stimulation of the rat parathyroid gland: an ultrastructural study. Ream, L.J., Principato, R. Am. J. Anat. (1981)
- Genetic dissection of phosphate- and vitamin D-mediated regulation of circulating Fgf23 concentrations. Yu, X., Sabbagh, Y., Davis, S.I., Demay, M.B., White, K.E. Bone (2005)
- Effects of 19-nor-1,25(OH)2D2, a new analogue of calcitriol, on secondary hyperparathyroidism in uremic rats. Slatopolsky, E., Finch, J., Ritter, C., Takahashi, F. Am. J. Kidney Dis. (1998)
- Deletion of deoxyribonucleic acid binding domain of the vitamin D receptor abrogates genomic and nongenomic functions of vitamin D. Erben, R.G., Soegiarto, D.W., Weber, K., Zeitz, U., Lieberherr, M., Gniadecki, R., Möller, G., Adamski, J., Balling, R. Mol. Endocrinol. (2002)
- Effects of magnesium and lactose supplementation on bone metabolism in the X-linked hypophosphatemic mouse. Marie, P.J., Travers, R. Metab. Clin. Exp. (1983)
- Intraoperative monitoring of intact PTH in surgery for renal hyperparathyroidism as an indicator of complete parathyroid removal. Elizondo, M.E., Díaz-Aguirregoitia, F.J., Amondarain, J.A., Vidaur, F. World journal of surgery. (2005)
- Comparative effect of oral or intravenous calcitriol on secondary hyperparathyroidism in chronic hemodialysis patients. Liou, H.H., Chiang, S.S., Huang, T.P., Shieh, S.D., Akmal, M. Mineral and electrolyte metabolism. (1994)